These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27317224)

  • 1. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
    Warda MH; Shehata SM; Zaiton F
    Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT.
    Seo JM; Park BK; Park SY; Kim CK
    AJR Am J Roentgenol; 2014 May; 202(5):1043-50. PubMed ID: 24758658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoma characterization: adrenal protocol with dual-energy CT.
    Kim YK; Park BK; Kim CK; Park SY
    Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed enhanced CT of lipid-poor adrenal adenomas.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
    AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
    Park BK; Kim CK; Kim B; Lee JH
    Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
    Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
    AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
    Szolar DH; Kammerhuber FH
    Radiology; 1998 May; 207(2):369-75. PubMed ID: 9577483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI.
    Wu YW; Tan CH
    Abdom Radiol (NY); 2016 Jun; 41(6):1170-7. PubMed ID: 26830419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
    Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
    AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
    Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
    Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unenhanced Dual-Layer Spectral-Detector CT for Characterizing Indeterminate Adrenal Lesions.
    Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Morinaga J; Ikeda O; Hirai T
    Radiology; 2021 Nov; 301(2):369-378. PubMed ID: 34427466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
    Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules.
    Jhaveri KS; Wong F; Ghai S; Haider MA
    AJR Am J Roentgenol; 2006 Nov; 187(5):1303-8. PubMed ID: 17056920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?
    Ho LM; Samei E; Mazurowski MA; Zheng Y; Allen BC; Nelson RC; Marin D
    AJR Am J Roentgenol; 2019 Mar; 212(3):554-561. PubMed ID: 30620676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
    Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
    Abdom Radiol (NY); 2024 May; 49(5):1626-1637. PubMed ID: 38456897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT sensitivity for adrenal adenoma according to lesion size.
    Park SY; Park BK; Park JJ; Kim CK
    Abdom Imaging; 2015 Oct; 40(8):3152-60. PubMed ID: 26254908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
    Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
    Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.